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Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human  neuronal differentiation The microRNAs (miRNAs) are an extensive class of small noncoding RNAs (18 to 25 nucleotides) with probable roles in the regulation of  gene expression. In Caenorhabditis elegans, lin-4 and let-7 miRNAs control the timing of fate specification of neuronal and hypodermal  cells during larval development. lin-4, let-7 and other miRNA genes are conserved in mammals, and their potential functions in mammalian  development are under active study.
Abstract
Background: The microRNAs (miRNAs) are an extensive class of small noncoding RNAs (18 to
25 nucleotides) with probable roles in the regulation of gene expression. In Caenorhabditis elegans,
lin-4 and let-7 miRNAs control the timing of fate specification of neuronal and hypodermal cells
during larval development. lin-4, let-7 and other miRNA genes are conserved in mammals, and their
potential functions in mammalian development are under active study.
Results:  In order to identify mammalian miRNAs that might function in development, we
characterized the expression of 119 previously reported miRNAs in adult organs from mouse and
human using northern blot analysis. Of these, 30 miRNAs were specifically expressed or greatly
enriched in a particular organ (brain, lung, liver or skeletal muscle). This suggests organ- or tissue-
specific functions for miRNAs. To test if any of the 66 brain-expressed miRNAs were present in
neurons, embryonal carcinoma cells were treated with all-trans-retinoic acid to promote neuronal
differentiation. A total of 19 brain-expressed miRNAs (including lin-4 and let-7 orthologs) were
coordinately upregulated in both human and mouse embryonal carcinoma cells during neuronal
differentiation. The mammalian ortholog of C. elegans lin-28, which is downregulated by lin-4 in
worms via 3' untranslated region binding, was also repressed during neuronal differentiation of
mammalian embryonal carcinoma cells. Mammalian lin-28 messenger RNAs contain conserved
predicted binding sites in their 3' untranslated regions for neuron-expressed miR-125b (a lin-4
ortholog), let-7a, and miR-218.
Conclusions:  The identification of a subset of brain-expressed miRNAs whose expression
behavior is conserved in both mouse and human differentiating neurons implicates these miRNAs
in mammalian neuronal development or function.
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Background
The microRNAs (miRNAs) are an extensive class of small
non-coding RNAs with mature transcripts of 18 to 25 nucleo-
tides [1-12]. The enzymatic machinery involved in the biogen-
esis of miRNAs in plants and animals is well conserved.
RNAse type III-like Dicer, together with Argonaute proteins,
cleaves a miRNA hairpin precursor (70 to 75 nucleotides) to
yield a stable, ~22 nucleotides miRNA from one arm of the
hairpin [13]. Some miRNA genes are often organized into
clusters [1-3,14,15], and in some cases clustered miRNAs are
co-expressed [14,15]. Coordinate transcription is the first of
multiple levels for regulation of miRNA expression, including
miRNA maturation, transport, and stability [15-17]. This
gives plants and animals a great flexibility to modulate the
levels of miRNAs in different cell types and tissues and at dif-
ferent stages of their development.
The biological functions of a handful of miRNAs have been
identified in plants and animals [13,18]. The most apparent
difference between plant and animal miRNAs is the way they
interact with target genes. A n i m a l  m i R N A s  a r e  g e n e r a l l y
thought to recognize their messenger RNA (mRNA) targets
by incomplete base-pairing, leading to translational inhibi-
tion of the target. Plant miRNAs apparently also inhibit trans-
lation [19], but many plant miRNAs are precisely
complementary to their targets, and in these cases they act as
guides to trigger transcript degradation through RNA inter-
ference (RNAi) [20-22]. In Caenorhabditis elegans, upregu-
lation of lin-4 and let-7 RNAs during the first and fourth
larval stage, respectively, triggers an ordered downregulation
of target genes that is required for the sequential expression
of stage-specific developmental programs [23-26]. lin-4 RNA
binds to the 3' untranslated region (UTR) of lin-14 and lin-28
mRNAs and inhibits their translation [27,28]. Similarly, let-7
RNA binds to 3' UTR of lin-41 and lin-57 mRNAs and inhibits
their expression at a post-transcriptional level [29-31]. In
Drosophila melanogaster, the mRNAs of the pro-apoptotic
gene hid and the apoptotic effector gene drice possess binding
sites for bantam and miR-14, respectively [32,33]. The phe-
notypes of bantam and mir-14 loss-of-function suggest that
these miRNAs regulate apoptosis by inhibiting translation of
these apoptosis-promoting genes [32,33].
In mammals, certain miRNAs have been implicated in the
maintenance of pluripotent cell state during early embryo-
genesis [34], and roles have been suggested for other miRNAs
in tissue-specific or organ-specific development [2]. How-
ever, hundreds of miRNAs have been cloned from mouse and
human organs and cell lines [1-3,9,10], and numerous addi-
tional miRNAs have been predicted with computational algo-
rithms [8]. To begin to explore the possible roles for these
numerous miRNAs in mammalia n  d e v e l o p m e n t ,  w e  u s e d
northern analysis to characterize the expression of 119 previ-
ously reported miRNAs in adult organs from mouse and
human. Of these, 30 miRNAs were specifically expressed or
greatly enriched in a particular organ, suggesting an organ- or
tissue-specific function. A small subset of brain-expressed
miRNAs was induced in mouse and human embryonal carci-
noma (EC) cells treated with all-trans-retinoic acid (RA).
This induction coincided closely with the time of terminal
neuronal differentiation. The evolutionary conserved expres-
sion of these miRNAs suggests that they may play a role in the
specification and/or progression of neuronal lineage. The
orthologous protein of C. elegans LIN-28 was repressed in
these EC cells treated with RA. In addition, mammalian Lin-
28 mRNAs contain conserved predicted binding sites in their
3' UTRs for neuron-expressed miR-125b (a lin-4 ortholog),
let-7a, and miR-218. Thus, Lin-28 may also be subjected to
miRNA regulation in mammalian cells.
Results and discussion
Diverse miRNA expression patterns in mammalian 
organs
Using northern analysis, we characterized the expression pat-
tern of 92 previously cloned miRNAs [1-3,9,10] and 27 com-
putationally predicted miRNAs [8] in adult organs from
mouse and human (Figure 1). This study confirms the expres-
sion of previously cloned miRNAs [1-3,9,10], and validates
the existence of computationally predicted miRNAs [8].
Although a wide range of expression profiles was represented
among these miRNAs, in general those miRNAs that had
been efficiently cloned from a particular organ in previous
studies [2,3], were also detected in those same organ(s) by
northern blot hybridization in this study. We detected 21 out
of 27 computationally predicted miRNAs by northern blot
hybridization. This result indicates that computational pre-
dictions are an appealing method for miRNA gene discovery
[8], but one should be cautious not to take computer predic-
tions as proof of existence until newly predicted miRNAs are
validated experimentally. The inability to detect some of the
cloned and predicted miRNAs might be due to low levels of
expression, expression limited to a small number of cells or in
a narrow window of time during development, or simply that
these miRNAs are not expressed in organs examined in this
study.
A total of 17 of the expressed miRNAs were detected exclu-
sively in a particular mouse organ; these included: seven
brain-specific miRNAs (miR-9, -124a, -124b, -135, -153, -183,
-219), six lung-specific miRNAs (miR-18, -19a, -24, -32, -130,
-213), two spleen-specific miRNAs (miR-189, -212), one liver-
specific miRNA (miR-122a), and one heart-specific miRNA
(miR-208) (Figure 2). All of the indicated mouse brain-, liver-
and heart-specific miRNAs were also detected in the human
counterpart organs (miRNA expression was not examined in
human kidney, lung or spleen), with the exception of miR-183
in the human brain. Among the 75 miRNAs that were
detected in two or more mouse organs, the levels of 14 of these
were detected in a particular mouse organ at levels at least
two-fold higher than in any other organ; these included:
seven brain-enriched miRNAs (miR-9*, -125a, -125b, -128,http://genomebiology.com/2004/5/3/R13 Genome Biology 2004,     Volume 5, Issue 3, Article R13       Sempere et al. R13.3
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-132, -137, -139), three skeletal muscle-enriched miRNAs
(miR-1d, -133, -206), two kidney-enriched miRNAs (miR-
30b, -30c), and one spleen-enriched miRNA (miR-99a) (Fig-
ure 2). All brain-enriched and skeletal muscle-enriched miR-
NAs had similar elevated levels in the human counterpart
organs. The high conservation of expression of these organ-
specific and organ-enriched miRNAs between mouse and
human suggests that they may play a conserved role in the
establishment and/or maintenance of a cell or tissue type of
that particular organ.
To identify additional classes of miRNAs with similar expres-
sion profiles, all 119 miRNAs were hierarchically clustered on
the basis of their expression profiles in our experiments,
applying Pearson's distribution. From this analysis, at least
six major groups of miRNAs with similar expression profiles
were discerned (Figure 2c). A group of six miRNAs was
expressed primarily in mouse spleen (miR-127, -142-a, -142-
s, -151, -189, -212). A group of five miRNAs was expressed in
mouse and human liver (miR-122a, -152, -194, -199, -215)
with some scattered expression in other organs including
The miRNA expression in mammalian organs and carcinoma cells Figure 1
The miRNA expression in mammalian organs and carcinoma cells. Mouse and human organs analyzed by northern blotting were brain (B), liver (Li), heart 
(H), skeletal muscle (M), lung (Lu), kidney (K), and spleen (S). P19 and NT2/D1 were treated with RA at time 0, cells were harvested and total RNA 
extracted at the indicated times (days). The miRNA levels detected by northern blot hybridization are represented as fold change of radioactive signal over 
background, as described in Materials and methods. The intensity of the yellow scale corresponds to the intensity of miRNA expression; black indicates no 
signal was detected over background, either by quantification or by visual inspection of the phosphoimager image. White indicates cases that were not 
tested. The stringency of hybridization was not sufficient to distinguish single nucleotide mismatches; very similar expression profiles were observed for 
members of closely related miRNA families, and so these profiles may reflect a composite of expression profiles from each member.R13.4 Genome Biology 2004,     Volume 5, Issue 3, Article R13       Sempere et al. http://genomebiology.com/2004/5/3/R13
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lung and kidney. A group of seven miRNAs was expressed in
mouse lung and kidney (miR-18, -20, -24, -32, -141, -193, -
200b). Together, the last two groups might reflect a role of
miRNAs in an epithelial cell type since liver, lung, and kidney
are organs containing epithelial tissues. A group of 17
miRNAs was expressed in mouse and human brain (miR-7, -
9, -9*, -124a, -124b, -125a, -125b, -128, -132, -135, -137, -139,
-153, -149, -183, -190, -219) with scattered expression in other
The miRNA expression profiles in mammalian organs Figure 2
The miRNA expression profiles in mammalian organs. (a) Distribution of all expressed miRNAs in mouse organs (center), miRNAs expressed only in a 
particular organ (right), and miRNA enriched in a particular organ at least two-fold over other organs (left). Note that mouse brain-specific miRNAs were 
detected at higher levels than mouse lung-specific miRNAs. Indeed, four of the seven brain-specific miRNA radioactive signals were detected at least two-
fold over background. (b) Northern blots of representative miRNAs with similar expression patterns in organs of mouse and human. (c) Clustering of 
expressed miRNAs by their similar expression profiles in mouse (Mm) and human (Hs) brain (B), liver (Li), heart (H), skeletal muscle (M), lung (Lu), kidney 
(K), and spleen (S). Note that some mouse lung-specific miRNAs (miR-19a, miR -130, miR -213) are also expressed in other human organs. Colored bars 
to the right of miRNA names refer to the corresponding color-coded classes in the right hand pie chart in (a): brain-specific (red), brain-enriched (purple), 
or lung-specific (light grey).http://genomebiology.com/2004/5/3/R13 Genome Biology 2004,     Volume 5, Issue 3, Article R13       Sempere et al. R13.5
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organs. This group included all seven brain-specific and
seven brain-enriched miRNAs described above. The brain is a
complex organ with several cell types, among which neurons
and glial cells are predominant. Future work will determine
the specific neuronal cells in which these miRNAs are
expressed. A group of six miRNAs was expressed in mouse
and human skeletal muscle and heart: miR-1b, -1d, -133 and -
206 had elevated expression in heart and skeletal muscle with
low expression in other organs and miR-143 and -208 were
almost exclusively detected in heart and skeletal muscle.
Skeletal muscle and heart derive from the mesodermal
embryonic layer and possess similar striated muscle cells.
Thus, these miRNAs could be developmentally expressed in
muscle cells of both organs. A group of five miRNAs showed
abundant expression across organs (let-7a, -7b, miR-30b, -
30c). let-7 family members have been suggested to play a role
in terminal differentiation during development in inverte-
brates and vertebrates [16]. Overall, about 50% of the
expressed miRNAs were assigned to a specific or restricted set
of organs. Other miRNAs had a more complex pattern of
expression and these were not readily assigned to a particular
group.
The majority of miRNAs presented here were previously
cloned by Lagos-Quintana and colleagues [2,3]. Our charac-
terization of organ expression of miRNAs correlates with the
organ(s) from which these miRNAS were originally cloned
[2,3]. miRNAs that were abundantly cloned in a particular
organ, such as miR-135 and miR-153 from brain [2], were
exclusively detected by northern analysis in mouse and
human brain. However, we observed some discrepancies
between our expression profiling by northern analysis and
expression profiling by cloning [2,3]. This is particularly so
for certain less-abundant miRNAs - those that were repre-
sented in size-selected RNA libraries by three or fewer copies.
We believe that northern analysis is a more statistically
robust method for expression profiling of less abundant miR-
NAs than cloning frequency is. The panel of organs that we
tested in our study did not include all the organs and tissues
that miRNAs were cloned from [1-3,9,10], and thus some
organ-specific or organ-enriched miRNAs may be expressed
in additional organs or tissues.
Coordinate expression of closely linked miRNAs
Closely linked miRNAs that are arranged in tandem often
exhibit similar expression profiles, consistent with shared cis-
regulatory elements, and possibly a polycistronic precursor
transcript. We observed similar expression profiles for the
pair of linked miRNAs, mir-194 and mir-215, and also for
both members of the mir-1d~mir-133 cluster (Figure 3). The
miR-1d~miR-133 hairpin precursors were found contained
within the same human cDNA clone (gi|34367728), suggest-
ing that miR-1d and miR-133 were expressed from the same
di-cistronic transcript.
We have also found several cases were closely linked miRNAs
are not tightly coexpressed. Closely linked miRNAs such as
mir-23b~mir-27b~mir-24/mir-189  exhibited more loosely
correlated expression patterns (Figure 3). However, a tran-
script containing miR-23b~miR-27b~miR-24/miR-189 was
detected by northern analysis in humans (gi|4105182), which
suggests that these clustered miRNAs probably belong to the
same transcriptional unit, but accumulate differentially in
vivo as a result of differences in post-transcriptional process-
ing or stability. Other cases of clustered miRNAs with differ-
ent expression profiles, such as mir-132 and mir-212, could
represent closely linked but independent transcription units.
miRNAs can be expressed from long transcripts
We found in GenBank [35] evidence that single, isolated
miRNA genes can be expressed from long transcripts. miR-9/
miR-9* and miR-145 were cloned in cDNA libraries from
human hypothalamus (gi|28436750) and trachea
(gi|21752921), respectively. Both miR-191 and miR-214 were
contained in long transcripts cloned in cDNA libraries from
mouse neonate head (gi|26096865) and eyeball
(gi|26094816), respectively. Where the miRNA transcrip-
tional unit starts is an important consideration since regula-
tory regions for miRNA transcription may reside kilobases
upstream of the predicted hairpin precursor. In other cases, a
miRNA may be regulated by a cryptic or nearby promoter. For
example,  mir-208, which is expressed in the mouse and
human heart, resides in an intron of human cardiac α-myosin
heavy chain. Perhaps mir-208  is co-transcribed with α-
myosin and then processed out.
Some miRNAs are associated with chromosomal 
rearrangements
Some miRNAs reside in genomic regions that have been asso-
ciated with a disease state. mir-15 and mir-16 reside on chro-
mosome 13q14, a region associated with chronic lymphocytic
leukemia (CLL) (Figure 3b). Calin et al. reported that miR-15
and miR-16 were expressed at reduced levels or unexpressed
at all in patients with CLL [36]. Notably, mir-142s/mir-142as
are located in the junction of the t(8;17) chromosomal rear-
rangement. This translocation fuses Bcl3 and Myc genes, thus
resulting in an aggressive B-cell leukemia [2,37]. mir-29
resides on chromosome 7q31. This FRA7G region is fre-
quently altered in different tumor types including prostate,
breast, and ovarian cancer [38]. It has also been hypothesized
that FRA7G region contains a tumor suppressor gene, which
is mutated during the development of these cancers or an
oncogene that is amplified [38]. It will be interesting to see if
miR-142s/miR-142as and miR-29 expression is altered in
patients with a t(8;17) chromosomal rearrangement or
mutated FRA7G region, respectively.
A subset of brain-expressed miRNAs is induced in 
retinoic acid-treated EC cells
We observed a high percentage of brain-specific and brain-
enriched miRNAs compared to miRNAs enriched or specificR13.6 Genome Biology 2004,     Volume 5, Issue 3, Article R13       Sempere et al. http://genomebiology.com/2004/5/3/R13
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to other organs (14 out of 30 miRNAs in mouse), and an over-
all prevalence of miRNAs expressed in the brain (66 out of 90
miRNAs in mouse). This suggested that miRNA-based
regulation of gene activity might be engaged during nervous
system development and neuronal differentiation. To deter-
mine which of brain-expressed miRNAs were associated with
neuronal differentiation, we examined their expression dur-
ing neuronal differentiation of EC cells. Mouse P19 and
human NTera-2 clone D1 (NT2/D1) are EC cells that differen-
tiate into neurons upon RA-treatment [39-41]. P19 and NT2/
D1 have similar programs of neuronal differentiation, though
the differentiation of P19 cells progresses more rapidly than
that of NT2/D1 cells [42,43]. An early phase of commitment
to neuronal fate occurs within two days after RA-treatment
for P19 and NT2/D1 cells. A later phase of terminal differen-
tiation takes place between days five to eight in P19 cells and
is delayed for more than three weeks in NT2/D1 cells [42,43].
We reasoned that miRNAs with evolutionarily conserved
roles in neurons should be induced during neuronal differen-
tiation of both mouse and human EC cells. P19 and NT2/D1
cells were treated with 1 µM and 10 µM of RA, respectively, to
induce neuronal differentiation. Cells were collected at key
days during differentiation and total RNA was analyzed by
northern blotting (Figures 1, 4). Remarkably, 19 miRNAs
were induced in both P19 and NT2/D1 cell lines (Figure 5).
They included four of the brain-specific (miR-9, -124a, -124b,
-135), four of the brain-enriched (miR-9*, -125a, -125b, -128),
and 11 of the brain-nonenriched (let-7a, let-7b, miR-30a,
Genomic organization and correlated expression of clustered miRNAs Figure 3
Genomic organization and correlated expression of clustered miRNAs. (a) In some miRNA clusters, all members of the cluster can be expressed in a 
highly correlated pattern; (b,c) for other clusters, the expression of different cluster members can vary in level or pattern. In some cases, entire clusters, 
or individual cluster members, have been cloned in human or mouse cDNA libraries, or detected by northern blot hybridization (dotted lines). Some 
miRNAs are associated with aberrant cytological locations (parenthesis). Chromosomal location of miRNAs is given by their cytological coordinates or 
BAC clone. Expression profiles are shown for mouse and human brain (B), liver (Li), heart (H), skeletal muscle (M), lung (Lu), kidney (K), and spleen (S).http://genomebiology.com/2004/5/3/R13 Genome Biology 2004,     Volume 5, Issue 3, Article R13       Sempere et al. R13.7
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
Genome Biology 2004, 5:R13
-30b, -30c, -30e, -98, -100, 103-1, -156, -218). The expression
of all 19 miRNAs was induced in P19 cells typically by day four
after RA-treatment and progressively accumulated to higher
levels thereafter. This time corresponds to a second wave of
transcriptional activation of protein-encoding genes that are
involved in terminal differentiation [44]. Thus, miRNA could
collaborate with or fine-tune the regulation mediated by neu-
rogenic proteins that specify neuronal identity. Since we did
not directly examine expression of miRNAs in glial cells, we
could not eliminate the possibility that RA-induced miRNAs
were also expressed in glial cells.
Only a subset of the brain-expressed miRNAs were detected
in neurons derived from RA-treated EC cells suggesting that
other brain-expressed miRNAs are present primarily in non-
neuronal cell types such as glia. Alternatively, these other
brain-expressed miRNAs may be present in neuronal sub-
types not represented in differentiated neurons derived from
EC cells. In a recent study, Krichevsky et al. described a series
of miRNAs that were developmentally regulated in rat brain
during corticogenesis [17]. We observed that the same series
of miRNAs was upregulated in EC cells upon RA-treatment.
Krichevsky  et al. also showed that miR-9/miR-9* were
expressed at lower levels in the presenillin-1 knockout mouse,
which had an abnormal forebrain development [17]. We
observed a strong induction of miR-9/miR-9* expression in
P19 cells. Together, these results suggest that miR-9/miR-9*
may play an important role during neurogenesis in rodents.
The coordinate activation of miRNAs (miR-9/9*, -103-1, -
124a, -124b, -128, -135, -156, -218) during neuronal differen-
tiation represents a global action of RA in the genome, since
The miRNA expression profiles in EC cells differentiating in response to RA Figure 4
The miRNA expression profiles in EC cells differentiating in response to RA. (a) Sets of miRNAs expressed in P19 and NT2/D1 cells treated with RA. All 
RA-induced miRNAs in P19 and NT2/D1 cells are also expressed in the brain (Figures 1, 2). Numbers in overlapping areas indicate the amount of miRNAs 
that belong to intersecting sets. (b) Clustering of the 19 miRNAs induced by RA-treatment in both P19 and NT2/D1 cells by their similar expression 
profile in mouse (Mm) and human (Hs) brain (B), liver (Li), heart (H), muscle (M), lung (Lu), kidney (K) and spleen (S). Colored bars to the right of miRNA 
names indicate miRNA expression classes in reference to the pie chart on the left: brain-specific (red), brain-enriched (purple), or brain-nonenriched 
(grey). (c) Northern blots of representative RA-induced miRNAs, constitutively expressed miRNAs (miR-92), and nonexpressed miRNAs (miR-1d) in P19 
and NT2/D1 cells treated with RA.R13.8 Genome Biology 2004,     Volume 5, Issue 3, Article R13       Sempere et al. http://genomebiology.com/2004/5/3/R13
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these miRNAs constitute unlinked loci. This contrasts with
the localized repression exerted by RA upon embryonic stem
cell-specific miRNAs (miR-290 to miR-295) arranged in two
tightly linked loci [34].
LIN-28 could be a potential target for miRNA 
regulation in embryonal carcinomas
The mir-125 and let-7 family members were among the brain-
expressed miRNAs induced during neuronal differentiation.
In C. elegans, lin-4 (the ortholog of mir-125) and let-7 are
engaged in a genetic pathway that controls temporal cell fates
during larval development [25,26]. Upregulation of lin-4
RNA during the first larval stage (L1) triggers the progression
from early (L1) to late (L2-L3) fate programs [24]. lin-4 RNA
binds to the 3' UTR of target mRNAs, including lin-28, and
inhibits their translation [27,45]. LIN-28 is expressed at early
stages in neuronal, hypodermal, and intestinal lineages
before it is developmentally downregulated by lin-4 RNA. In
mammals, LIN-28 protein is downregulated as embryonic
development progresses, consistent with a possible con-
served role in developmental timing [46]. Interestingly, LIN-
28 is present in undifferentiated P19 and NT2/D1 cells, but it
is not detected in neuronal or liver tissues [46]. To test if
downregulation of LIN-28 could occur in conjunction with
neuronal differentiation, western analysis of total protein
from lysates of P19 and NT2/D1 cells was performed at vari-
ous times after RA-treatment. LIN-28 levels began to
decrease on about day five after RA-treatment, and almost
disappeared by day eight, when cells reached their final state
of neuronal differentiation. A similar result was observed in
NT2/D1 cells; LIN-28 levels decreased slightly, typically by
day 14, and were still detectable at day 21. The kinetics of LIN-
28 downregulation in P19 and NT2/D1 cells during RA-
induced differentiation parallels the upregulation of miR-
125b, let-7a, and miR-218 in these EC cells. The 3' UTRs of the
mouse and human Lin-28 mRNAs contain conserved
sequences complementary to miR-125b, let-7a, and miR-218
(Figure 5) [46], consistent with a role for these miRNAs in the
downregulation of LIN-28 in NT2/D1 and P19 cells. Yet, we
did not detect downregulation, in differentiating P19 cells, of
a luciferase reporter gene fused to the mouse Lin-28 3' UTR
and driven by a cytomegalovirus (CMV) or thymidine kinase
(TK) promoter (data not shown). We also noticed a decrease
in endogenous Lin-28 mRNA levels in differentiated neurons
derived from P19 cells (data not shown), suggesting that
repression of the native Lin-28 gene in this system may be
largely transcriptional. These results therefore suggest that,
unlike C. elegans larval development, where lin-28 downreg-
ulation is primarily caused by translational repression by lin-
4 RNA, the decline of Lin-28 during neuronal differentiation
LIN-28: a potential miRNA target in P19 and NT2/D1 cells Figure 5
LIN-28: a potential miRNA target in P19 and NT2/D1 cells. (a) Western blot of LIN-28 protein in P19 and NT2/D1 cells treated with RA at day 0. Actin 
is shown as loading control for protein concentration. (b) Depiction of 3' UTR of mouse Lin-28 mRNA, colored blocks indicated strong sequence 
homology with human Lin-28 3' UTR. Colored bars indicate predicted miRNA sites on Lin-28 3' UTR conserved blocks. Insets of block 2 and block 3 show 
predicted RNA-RNA interaction of Lin-28 3' UTR and RA-induced let-7a, miR-125b, and miR-218.http://genomebiology.com/2004/5/3/R13 Genome Biology 2004,     Volume 5, Issue 3, Article R13       Sempere et al. R13.9
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of P19 cells involves primarily transcriptional repression.
However, the phylogenetic conservation of miRNA sites sug-
gests that translational repression of Lin-28 by let-7a, miR-
125b, and/or miR-218 may contribute secondarily to Lin-28
downregulation in the mammalian system.
Myc and Cyclin D1 are well-characterized cases of genes
repressed by RA-treatment at the levels of transcription and
translation in differentiating neurons [47,48]. We subjected
the conserved blocks between mouse and human Myc and
Cyclin D1 3' UTRs to the same computer algorithm applied to
Lin-28 3' UTR to identify potential binding sites for RA-
induced miRNAs. Potential sites for let-7 and miR-30 family
members were found on Myc and Cyclin D1 3' UTRs (data not
shown). These findings suggest that translational repression
by miRNAs, in combination with transcriptional repression
and mRNA turnover, could contribute to the downregulation
of growth and cell cycle regulators during neuronal
differentiation.
Conclusions
Hundreds of miRNAs have recently been discovered in mam-
malian genomes. To begin to explore the potential roles of
these miRNAs in mammalian development and physiology,
we characterized the expression profiles of 119 miRNAs in
mouse and human organs (Figure 1). We found that many of
these miRNAs exhibit phylogenetically conserved organ-
enriched or organ-specific expression. In both mouse and
human examined organs, seven miRNAs were expressed spe-
cifically in a particular organ and ten miRNAs were greatly
enriched in a particular organ over all others (Figure 2).
These data associate miRNAs to particular organs and sug-
gest their participation in conserved developmental or physi-
ological pathways within these spatial domains in mouse and
human. Interestingly, 13 of these 17 miRNAs were enriched or
specifically expressed in brain of both mouse and human. Of
these, eight brain miRNAs were also induced during differen-
tiation of neurons derived from human and mouse EC cells
treated with RA (Figure 4). These data strongly suggest a con-
served role for these miRNAs in the specification and/or pro-
gression of neuronal fate in mammals. At least one gene
whose protein product decreases during neuronal differenti-
ation, Lin-28, contains potential sites in its 3' UTR for com-
plementary base-pairing by the RA-induced miRNAs let-7a,
miR-125b, and miR-218 (Figure 5). However, not only the
protein levels but also the RNA levels of Lin-28 decreased
upon RA treatment suggesting that other factors must also
mediate this process. Unlike C. elegans lin-28 whose transla-
tional inhibition by lin-4 RNA is the primary mechanism for
its downregulation, miRNAs may provide an auxiliary or rein-
forcing layer of regulation to completely shut down Lin-28
expression in EC cells. miRNA loss-of-function experiments
in these EC cells could prove useful in understanding their
regulatory contribution during the process of neuronal differ-
entiation. In the case of targets whose expression is primarily
controlled on the translational level, miRNAs could play a pri-
mary regulatory role; in other cases, such as mammalian Lin-
28, where the primary mode of regulation is transcriptional,
translational repression by miRNAs could play an auxiliary,
or supplementary regulatory role.
Materials and methods
Cell culture and retinoic acid treatment
P19 cells were cultured in αMEM with 7.5% fetal calf serum
and 2.5% fetal bovine serum supplemented with streptomy-
cin and penicillin; NT2/D1 cells were cultured in high glucose
DME with 10% fetal bovine serum supplemented with peni-
cillin, streptomycin, and glutamine under humidified 5%
CO2. P19 cells were treated with 1 µM RA solution as
described in [40]; NT2/D1 were treated with 10 µM RA solu-
tion as described in [49]. Control cells were treated with an
equal amount of the vehicle dimethyl-sulfoxide.
Northern analysis
Frozen dissected organs from six-week-old C57BL/6 mice
were a gift from Nathan Watson (Norris Cotton Cancer
Center at Dartmouth-Hitchcock Medical Center). Total RNA
was extracted from pooled organs of two to four mice or from
cell lines with Trizol Reagent following the vendor's recom-
mendations. Total RNA, 5 or 10 µg, was routinely loaded onto
12% urea-polyacrylamide gels as described in [50]. Total RNA
from human organs was acquired from the Biochain Institute.
Membranes were stripped by boiling in 0.1% SDS and re-
hybridized up to five times without observing decreases in
quality or intensity of radioactive signals.
StarFire oligonucleotide probes
We used StarFire probes, radioactively labeled with [α-32P]-
dATP 6000 Ci/mmol following vendor's recommendations.
T h e  c o m p l e t e  l i s t  o f  S t a r F i r e  p r o b e s  u s e d  i n  t h i s  s t u d y  i s
enclosed in the additional data file.
Data clustering
Radioactivity contained in northern blot bands was quanti-
fied with the ImageQuant software package, and was
expressed as a ratio of signal in the band of hybridization to
signal in the background adjacent to the band. Hybridization/
background ratios of ≤ 1.1 were not reported as positive sig-
nals, except when the band was readily detectable by eye (Fig-
ures 2, 5). Northern hybridization data were clustered with
GeneTraffic 6.2 software package, applying Pearson's hierar-
chical clustering.
miRNA::target mRNA predictions
Potential RNA::RNA interactions between miRNAs and 3'
UTR sequences were assessed by testing 20-nts segments of
3' UTR sequence for their predicted capacity to form RNA
secondary structure with a candidate miRNA. Each miRNA
sequence was appended to each 20-nucleotide 3' UTR seg-
ment by a poly-(N)10 linker, and analyzed for predicted RNAR13.10 Genome Biology 2004,     Volume 5, Issue 3, Article R13       Sempere et al. http://genomebiology.com/2004/5/3/R13
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secondary structure using the RNAfold program of the
Vienna RNA package [51]. The full length of a 3' UTR
sequence was queried by extracting successive 20-nucleotide
test segments, tiling along in two-nucleotide steps. RNA fold-
ing output generated by ViennaRNA was analyzed using the
following software filters to evaluate the strength of the pre-
dicted target::miRNA interaction: at least two out of the three
first and last bases of the miRNA had to be bound to the target
sequence; at least 65% of the miRNA sequence had to be
bound to the target sequence; the free energy (∆G) of the
binding had to be greater than -7 Kcal/mole; and the
target::miRNA interaction site had to lie within regions of at
least 76% identity between mouse and human target 3' UTRs.
The scoring scheme was modeled based on the experimen-
tally confirmed interaction between lin-4 RNA::lin-28 3' UTR
in C. elegans. Those predicted miRNA::UTR structures that
passed the above filters were further assigned a numerical
score based on the following parameters: total number of
miRNA bases bound to a target sequence - points for binding
were weighed, having a less impact on the score of a mismatch
in the central region of the miRNA, which tends to bulge out
in documented miRNA/mRNA interactions [23,45] (denoted
(a)); number of consecutive miRNA bases bound to target
sequence (denoted (b)); overall ∆G of RNA-RNA interaction
(denoted (c)); and additional emphasis for miRNA with the
first three and last three bases bound to target sequence
(denoted (d)). This is the formula of the overall score = 8a +
2b + 84c + 6d.
Additional data file
The complete list of StarFire probes used in this study is pro-
vided in Additional data file 1, available with the complete
version of this article, online.
Additional data file 1 The complete list of StarFire probes used in this study The complete list of StarFire probes used in this study Click here for additional data file
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